Bruce McCall
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Otorhinolaryngology top 10%
Papers in
- Oncology 8
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Maria Anderson (5 shared papers)Amy V. Kapp (4 shared papers)Andrea Pirzkall (4 shared papers)Lori J. Wirth (2 shared papers)Antonio Jimeno (2 shared papers)Elicia Penuel (3 shared papers)Ina Rhee (4 shared papers)Chi‐Chung Li (4 shared papers)
- Journals
- The Oncologist (3 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)American Journal of Nephrology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Bruce McCall
13 papers receiving 384 citations
Peers
Comparison fields: 5 of 41
- Oncology 258
- Otorhinolaryngology 25
- Immunology 86
- Radiology, Nuclear Medicine and Imaging 90
- Genetics 32
Countries citing papers authored by Bruce McCall
This map shows the geographic impact of Bruce McCall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce McCall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce McCall more than expected).
Fields of papers citing papers by Bruce McCall
This network shows the impact of papers produced by Bruce McCall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce McCall. The network helps show where Bruce McCall may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce McCall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | 2016 | 57 | |
| 3 | 2018 | 45 | |
| 4 | 2016 | 38 | |
| 5 | 2014 | 37 | |
| 6 | 2013 | 27 | |
| 7 | 2017 | 26 | |
| 8 | 2017 | 23 | |
| 9 | 2018 | 19 | |
| 10 | 2018 | 18 | |
| 11 | 2021 | 6 | |
| 12 | 2015 | 5 | |
| 13 | 2019 | 3 | |
| 14 | 1990 | 1 |
About Bruce McCall
Bruce McCall is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 391 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Potassium and Related Disorders (1 paper), Cancer Genomics and Diagnostics (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Oncology (258 citations), Otorhinolaryngology (25 citations), Immunology (86 citations), Radiology, Nuclear Medicine and Imaging (90 citations) and Genetics (32 citations). Bruce McCall has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Maria Anderson, Amy V. Kapp, Andrea Pirzkall, Lori J. Wirth, Antonio Jimeno, Elicia Penuel, Ina Rhee, Chi‐Chung Li, Richard J. Glassock and Paul M. Harari. Their work appears in journals such as The Oncologist, Blood, Journal of Clinical Oncology, American Journal of Nephrology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.